SCHEMBL21362731

SCHEMBL21362731

CSCc1ccc(C(=O)c2ccc(P)cc2)c(Br)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.38
RAB9A P51151 4/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 5/20 0.36
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
RXRA P19793 1/20 0.35
HTT P42858 2/20 0.34
HPGD P15428 3/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
SRD5A2 P31213 2/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157757 0.86 LMNA (0.50) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL20157580 0.73 LMNA (0.37) RAB9ASMN1; SMN2LMNAMAPTKMT2A
SCHEMBL20157814 0.73 KMT2A (0.41) NPC1RAB9ALMNAMAPTKMT2A
SCHEMBL20157553 0.72 POLB (0.36) SMN1; SMN2LMNAHPGDALDH1A1
SCHEMBL20158008 0.72 HPGD (0.40) NPC1RAB9ALMNAMAPTHPGD
SCHEMBL20157918 0.71 MAPT (0.48) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL20157960 0.71 SRD5A2 (0.49) NPC1RAB9ALMNAMAPTRXRA
SCHEMBL21362717 0.71 CES2 (0.38) NPC1RAB9ASMN1; SMN2MAPTRXRA
SCHEMBL7995645 0.71 RAB9A (0.57) NPC1RAB9ASMN1; SMN2LMNAMAPT
SCHEMBL4967339 0.70 MAPT (0.47) NPC1RAB9ASMN1; SMN2MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed